A multivariable model combining four quantitative shear-wave elastography parameters differentiated benign and malignant BI-RADS category 4 breast lesions with higher accuracy than individual metrics, according to a retrospective single-center study conducted by researchers at Hengyang Central Hospital and the Hunan Institute of Traffic Engineering. Evaluating 454 pathologically confirmed lesions, the combined diagnostic model achieved an area under the receiver-operating characteristic curve of 0.948, demonstrating superior discriminatory capacity compared to single elastographic measurements.
Conducted between 2022 and 2025, the investigation enrolled 454 patients with pathologically confirmed BI-RADS 4 breast lesions, evaluating exactly one lesion per patient. All participants underwent imaging with conventional ultrasound alongside quantitative shear-wave elastography. Clinicians established BI-RADS subcategories of 4A, 4B, and 4C prior to the acquisition of shear-wave elastography measurements. Subsequent pathological confirmation revealed that 277 lesions, representing 61.01 percent of the total cohort, were benign, while 177 lesions, accounting for 38.99 percent, were malignant.
The research team recorded four specific quantitative shear-wave elastography parameters for each examined lesion: maximum elasticity (Emax), mean elasticity (Emean), minimum elasticity (Emin), and the elasticity ratio (Eratio). Across all four parameters, measured values were significantly higher in malignant lesions than in benign lesions, with all comparisons yielding p-values of less than 0.001. In multivariable logistic regression analysis, each of the four quantitative parameters remained an independent predictor of malignancy.
Specifically, the multivariable logistic regression model indicated that each 1-kilopascal increment was associated with increased odds of malignancy across the individual tissue stiffness metrics. Emax demonstrated an odds ratio of 1.106 with a 95 percent confidence interval ranging from 1.073 to 1.140 (p < 0.001). Emean yielded an odds ratio of 1.115 with a 95 percent confidence interval of 1.080 to 1.152 (p < 0.001), while Emin showed an odds ratio of 1.101 with a 95 percent confidence interval of 1.053 to 1.151 (p < 0.001). The elasticity ratio exhibited an odds ratio of 2.438 per 1-unit increment, with a 95 percent confidence interval from 1.875 to 3.170 (p < 0.001).
By integrating all four elastography parameters into a unified multivariable logistic regression model, the investigators achieved an overall area under the curve of 0.948 with a 95 percent confidence interval of 0.926 to 0.970. Paired DeLong testing confirmed that this combined model significantly outperformed each individual parameter on its own (all p < 0.001). At this performance level, the model achieved a diagnostic sensitivity of 84.75 percent and a specificity of 93.86 percent. Internal validation conducted via bootstrap resampling established an optimism-corrected area under the curve of 0.945.
To explore whether the model could identify lesions that might safely avoid immediate biopsy, the investigators applied the model probability as a standalone post-hoc exploratory decision rule using a probability cut-off of 0.32. Under this criterion, 255 lesions, or 56.17 percent of the cohort, were categorized as low-risk. However, this designated low-risk group still contained 17 pathologically confirmed malignant lesions. This yielded an apparent negative predictive value of 93.33 percent and an apparent missed-cancer rate of 9.60 percent, which adjusted to 92.96 percent and 10.14 percent, respectively, following bootstrap correction.
Because the post-hoc exploratory rule resulted in missed cancers, the authors concluded that the rule failed to demonstrate that immediate tissue biopsy could be safely avoided in clinical practice. Although quantitative shear-wave elastography differentiated benign from malignant lesions and offers potential for reducing unnecessary benign biopsies if validated prospectively, the authors emphasized significant study limitations, including its single-center retrospective design and the absence of external validation. Consequently, the research team noted that these preliminary observations require prospective multicenter confirmation before any clinical implementation can be considered.
Subject of Research: Quantitative shear-wave elastography for differentiating and reclassifying BI-RADS category 4 breast lesions
Article Title: Diagnostic performance of quantitative shear-wave elastography for reclassifying BI-RADS category 4 breast lesions: a retrospective single-center study
Article References: Long, M., Xiao, H., Yang, J., He, M., & Hu, L. (2026). Diagnostic performance of quantitative shear-wave elastography for reclassifying BI-RADS category 4 breast lesions: a retrospective single-center study. Frontiers in Public Health, 14, Article 1891455. https://doi.org/10.3389/fpubh.2026.1891455
Image Credits: AI Generated
DOI: 10.3389/fpubh.2026.1891455
Keywords: shear-wave elastography, BI-RADS 4, breast lesions, breast cancer diagnosis, ultrasonography, Emax, Emean, Emin, elasticity ratio, multivariable logistic regression, receiver-operating characteristic, DeLong test, bootstrap resampling, biopsy reduction, optimism-corrected AUC, negative predictive value, missed-cancer rate, Hengyang Central Hospital
News Source: Ophelia Keating. (November 12, 2026). Four Elastography Parameters Improve Diagnostic Discrimination in Suspicious Breast Lesions. Scienmag.



